Modest Increase in Mesothelioma Survival from Chemotherapy

The chemotherapy combination that has become the standard of care for mesothelioma in many parts of the world appears to be making a modest but measurable difference for mesothelioma patients in The Netherlands.

Mesothelioma is caused almost exclusively by inhalation or ingestion of asbestos fibers and is notoriously resistant to most conventional treatments.

Within the last decade, chemotherapy with cisplatin-antifolate combinations has been shown to improve responses and prolong survival. 

Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , , , , , | Leave a comment

Vatalanib Not Effective as a ‘Single Agent’ for Mesothelioma

There has been a setback for doctors hoping the drug vatalanib would be a viable alternative to chemotherapy for mesothelioma patients.

Scientists with the Cancer and Leukemia Group B (CALGB), a research team based at the University of California, have ruled out further study on the medication as a single agent (administered by itself) after a phase II trial found no significant survival benefit among mesothelioma patients. 

Vatalanib is an oral medicine classified as an anti-angiogenesis drug, designed to inhibit the formation of ew blood vessels necessary to ‘feed’ a growing tumor.

Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , , | Leave a comment

National Cancer Institute Opening Two New Trials For Mesothelioma Patients

The steps often have been slow, but Dr. Raffit Hassan in Bethesda, Maryland, keeps plugging away in the search for better options to treat malignant mesothelioma.

He never has been more optimistic.

Hassan, a senior investigator at the National Cancer Institute, has opened two new clinical trials for patients who already have received standard care that has failed to be effective.

Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , | Leave a comment

Brighton base for new centre at forefront of cancer research

A major centre which will carry out groundbreaking trials of the latest treatment for critically ill cancer patients is to be based in Brighton.

Experts say the Experimental Cancer Medical Centre will benefit patients in Sussex and put Brighton at the forefront of cancer research.

Patients taking part in these early trials cannot usually be helped by existing treatments, such as conventional radiotherapy and chemotherapy.

Continue reading

Posted in National Asbestos | Tagged , | Leave a comment

Construction Workers And Electricians At High Risk Of Asbestos Exposure

Asbestos exposure is known to cause:

Statistics show it is particularly prevalent amongst construction workers and electricians due to their constant contact with construction materials and dust, some of which is likely to include asbestos, no matter how careful they are.

Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Modest Increase in Mesothelioma Survival from Chemotherapy

The chemotherapy combination that has become the standard of care for mesothelioma in many parts of the world appears to be making a modest but measurable difference for mesothelioma patients in The Netherlands.

Mesothelioma is caused almost exclusively by inhalation or ingestion of asbestos fibers and is notoriously resistant to most conventional treatments.

Within the last decade, chemotherapy with cisplatin-antifolate combinations has been shown to improve responses and prolong survival. 

Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , , | Leave a comment

Mesothelioma Lawsuit Reveals Rare Case of Short Asbestos Exposure

Roger Hammett was awarded $1.45 million on Thursday after a jury ruled that his mesothelioma cancer was caused by asbestos exposure from a job that he held 45 years ago.

The case also revealed something interesting that is not often seen in most mesothelioma cases: Hammett developed mesothelioma after only working 67 days around asbestos.

The December 15 verdict may provide Hammett with some justice now that he is only expected to live for one more year, but it may also provide some clarity into the relationship between asbestos exposure and this aggressive cancer.

Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Mesothelioma: Vaccine May Enlist Body’s Immune System to Kill Mesothelioma Cancer Cells

Researchers at the Mayo Clinic and the University of Georgia have developed a vaccine that may offer a promising new strategy for treating various cancers including mesothelioma.

An aggressive cancer associated with breathing asbsestos, mesothelioma originates most often in the lining of the lung and abdominal cavity.

The vaccine, which has shown dramatic results at reducing tumors in mice in laboratory experiments, helps a cancer patient’s immune system identify cancer cells and kill them, according to an article this week in the Proceedings of the National Academy of Sciences.

Treatments that employ the body’s own defenses are known as immunotherapy.  The research was funded by the National Cancer Institute.

Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , | Leave a comment

Red Cross to review status of board member tied to asbestos industry

The Canadian Red Cross will review the status of one of its board members after critics called for the Montrealer to be dumped from the humanitarian organization because of her connection to the asbestos industry.

The governing body of the Red Cross is tackling the sensitive topic of the private interests of Roshi Chadha at its January meeting, Postmedia News has confirmed.

Chadha is an executive of Montreal-based Seja Trade Ltd., a subsidiary of Balcorp Ltd. that has for years exported asbestos from the open-pit Jeffrey asbestos mine in Quebec to India. Her husband, Baljit Singh Chadha, is seeking to revive the Quebec asbestos industry as the president of Balcorp.

Continue reading

Posted in National Asbestos | Tagged | Leave a comment

Mesothelioma: Power station worker died from asbestos

A SELBY man who worked in power stations for 27 years died from a lung disease after consistent exposure to asbestos, an inquest heard on Tuesday.

Thomas Sinclair, of Woodville Terrace, died on November 9 this year after he was suffering with shortage of breath and chest pains after a fall at home.

Doctors at York Hospital diagnosed the 82-year-old with malignant lung diseasemesothelioma – but because of its advanced state ruled out chemotherapy and discharged him to be cared for at home.

Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , | Leave a comment